Previous close | 0.0500 |
Open | 0.0400 |
Bid | 0.0200 |
Ask | 0.0400 |
Strike | 15.50 |
Expiry date | 2024-07-05 |
Day's range | 0.0400 - 0.0400 |
Contract range | N/A |
Volume | |
Open interest | 49 |
TEL AVIV, Israel, June 25, 2024--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has entered an agreement with the Israel Tax Authority (the "ITA") resolving all pending litigation with respect to taxes payable for the Company's taxable years 2008-2020. Under the terms of the agreement the Company will pay a total of $750 million in installments between 2024 to 2029.
PARSIPPANY, N.J., June 24, 2024--Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.
Here, we discuss some reasons why buying Alvotech (ALVO) stock now may turn out to be a prudent move.